Skip to main content
Premium Trial:

Request an Annual Quote

MDS Proteomics Names New CFO, Eyes IPO in 02

NEW YORK, Dec. 11 - MDS Proteomics on Tuesday has named Anil K. Amlani to be its chief financial officer.


According to the company, he will be responsible for "driving and maintaining further financial growth and development" and will report directly to Frank Gleeson, MDS Proteomics' president and CEO.


"Anil's financial expertise, his strong relationships with the investment and analyst community, and his established technology background will play an essential role in helping MDS Proteomics to determine financing opportunities, including the possibility of an IPO in 2002," Gleeson said in a statement.


"Anil will also assist us greatly in our ongoing negotiations with top-tier pharmaceutical and biotechnology companies concerning broad commercial collaborations," he added.


Before joining Toronto-based MDS Proteomics, Amlani was senior vice president and CFO of Cancom, Canadian Satellite Communications where he headed business planning and financing for all operating units and oversaw all principal investments.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.